JZP-MA-11 (1.5 mg/kg; IV; 20 min before tracer injection) results in a decrease in radioactivity uptake in ABHD6-rich organs such as, brain, liver, heart, and kidneys[1].
| Animal Model: | C57BL6 mice (female, 10-12-week-old)[1] |
| Dosage: | 1.5 mg/kg |
| Administration: | IV; 20 min before tracer injection |
| Result: | Resulted in a decrease in radioactivity uptake in ABHD6-rich organs such as, brain, liver, heart, and kidneys. |
